[Review [New antibiotics series VI]: Ceftizoxime (author's transl)].
D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy*; D002439:Cefotaxime / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D015296:Ceftizoxime; D004341:Drug Evaluation; D004355:Drug Stability; D004697:Endocarditis, Bacterial / Q000188:drug therapy; D005260:Female; D005831:Genital Diseases, Female / Q000188:drug therapy; D006801:Humans; D012141:Respiratory Tract Infections / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy; D001618:beta-Lactamases
D015296:Ceftizoxime; D001618:beta-Lactamases; D002439:Cefotaxime